Pa Shun International Holdings Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Pa Shun International Holdings.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Healthcare winstgroei | 22.1% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Revenues Working Against Pa Shun International Holdings Limited's (HKG:574) Share Price Following 30% Dive
Sep 02
Pa Shun International Holdings Limited's (HKG:574) Business And Shares Still Trailing The Industry
Jun 04Pa Shun International Holdings Limited (HKG:574) Shares May Have Slumped 33% But Getting In Cheap Is Still Unlikely
Feb 18Investors Aren't Buying Pa Shun International Holdings Limited's (HKG:574) Revenues
Dec 19Is Pa Shun International Holdings (HKG:574) Using Debt In A Risky Way?
Apr 05Pa Shun International Holdings (HKG:574) Has Debt But No Earnings; Should You Worry?
Sep 05Is Pa Shun International Holdings (HKG:574) Using Too Much Debt?
May 24Read This Before Selling Pa Shun International Holdings Limited (HKG:574) Shares
Dec 15
In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Pa Shun International Holdings onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2024 | 95 | 33 | -55 | -55 | N/A |
| 3/31/2024 | 112 | 18 | -45 | -45 | N/A |
| 12/31/2023 | 129 | 2 | -35 | -35 | N/A |
| 9/30/2023 | 125 | -16 | -14 | -14 | N/A |
| 6/30/2023 | 121 | -34 | 6 | 6 | N/A |
| 3/31/2023 | 97 | -39 | 2 | 2 | N/A |
| 12/31/2022 | 72 | -43 | -2 | -2 | N/A |
| 9/30/2022 | 71 | -186 | -14 | -14 | N/A |
| 6/30/2022 | 71 | -328 | -25 | -25 | N/A |
| 3/31/2022 | 78 | -329 | -24 | -23 | N/A |
| 12/31/2021 | 86 | -330 | -22 | -22 | N/A |
| 9/30/2021 | 175 | -373 | -6 | -6 | N/A |
| 6/30/2021 | 265 | -416 | 14 | 14 | N/A |
| 3/31/2021 | 370 | -417 | 1 | 1 | N/A |
| 12/31/2020 | 475 | -418 | -12 | -12 | N/A |
| 9/30/2020 | 563 | -313 | -37 | -36 | N/A |
| 6/30/2020 | 652 | -207 | -67 | -66 | N/A |
| 3/31/2020 | 748 | -200 | -63 | -62 | N/A |
| 12/31/2019 | 845 | -194 | -59 | -58 | N/A |
| 9/30/2019 | 850 | -128 | -84 | -58 | N/A |
| 6/30/2019 | 855 | -63 | -108 | -58 | N/A |
| 3/31/2019 | 838 | -61 | -71 | -20 | N/A |
| 12/31/2018 | 821 | -59 | -33 | 18 | N/A |
| 9/30/2018 | 861 | -26 | -30 | 31 | N/A |
| 6/30/2018 | 900 | 8 | -28 | 45 | N/A |
| 3/31/2018 | 885 | 9 | N/A | -26 | N/A |
| 12/31/2017 | 870 | 10 | N/A | -96 | N/A |
| 9/30/2017 | 877 | -3 | N/A | -78 | N/A |
| 6/30/2017 | 884 | -16 | N/A | -60 | N/A |
| 3/31/2017 | 872 | -4 | N/A | -30 | N/A |
| 12/31/2016 | 861 | 8 | N/A | -1 | N/A |
| 9/30/2016 | 821 | 23 | N/A | 6 | N/A |
| 6/30/2016 | 780 | 39 | N/A | 12 | N/A |
| 3/31/2016 | 824 | 64 | N/A | -11 | N/A |
| 12/31/2015 | 868 | 88 | N/A | -35 | N/A |
| 9/30/2015 | 882 | 99 | N/A | -41 | N/A |
| 6/30/2015 | 896 | 109 | N/A | -48 | N/A |
| 3/31/2015 | 872 | 77 | N/A | 0 | N/A |
| 12/31/2014 | 847 | 46 | N/A | 49 | N/A |
| 12/31/2013 | 794 | 63 | N/A | 92 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if 574's forecast earnings growth is above the savings rate (2.3%).
Winst versus markt: Insufficient data to determine if 574's earnings are forecast to grow faster than the Hong Kong market
Hoge groeiwinsten: Insufficient data to determine if 574's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if 574's revenue is forecast to grow faster than the Hong Kong market.
Hoge groei-inkomsten: Insufficient data to determine if 574's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if 574's Return on Equity is forecast to be high in 3 years time